Abstract-The effects of the active principles of crude ginger (a traditional Sino Japanese medicine), the gingerols, on the contractile responses to eicosanoids were compared using isolated mouse and rat blood vessels. Leukotrienes (LT) C4 and D4, a thromboxane (TX) A2 derivative (U-46619), prostaglandins (PG) F2a, PG12-Na, PGE2, the stable PG12 derivative TRK-100, and PGD2 induced con traction in longitudinal segments of mouse mesenteric veins in that order of potency. Exogenous arachidonic acid and PGE, did not cause contraction. The mesenteric veins also contracted in response to noradrenaline (NA) and phenylephrine (PhE), but not to clonidine. The gingerols alone relaxed the muscle transiently and then augmented the response to PGF2a, PGE2, PG12-Na, and TRK-100, but suppressed the response to PGD2, U-46619, LTC4, LTD4, NA and PhE. (±)-[6]-Gingerol also potentiated the PGF2a-induced contraction in longitudinal segments of rat mesen teric vein and vena cava, but inhibited it in circular segments of rat aorta and longi tudinal segments of mouse mesenteric arteries. These results showed that (±) 
Physiologically active eicosanoids such as the PG, TX and LT either dilate or constrict the vasculatures.
PG 12, PGF2a, PGE2, PGD2 and TXA2 are synthesized in the blood vessels (1) and are involved in the modulation of con traction in vascular smooth muscles. Similarly, LTC4 and LTD4 induce contraction of mesen teric vascular tissues (2) .
The gingeroles are major constituents of the rhizomes of crude ginger, Zingiber officinale (a traditional Sino-Japanese me dicine). We have previously demonstrated that the gingerols and other related com pounds suppressed calcium spikes and spon taneous contraction in mouse portal veins (3) . Furthermore, we have reported the essential moiety in the chemical structure of gingerol derivatives necessary for potentiation of PGF2a-induced contration in mouse mesen teric veins (4) . In the present study, the ex periments were designed to evaluate the effects of gingerols on the contraction in duced by various eicosanoids on isolated blood vessels of mice and rats because the gingerols have prostaglandin-related chemical structures.
These will provide new insight into the pharmacological action of gingerols as a modulator of eicosanoid responses in vascular smooth muscles.
Materials and Methods
Tissue preparation:
The artery and vein specimens from male Wistar rats (6-7 weeks old, 190-300 g), and male ddY mice (7-9 weeks old, 30-40 g) were used. The rats were killed under anesthesia with sodium pen tobarbital, 50 mg/kg, i.p., whereas the mice were killed by decapitation.
The vascular smooth muscles were rapidly excised and cleaned of adhering fat and mucosa while immersed in a modified Krebs' solution (pH 7. 4-7.5) containing: 122 mM NaCI, 5.9 mM KCI, 15.5 mM NaHCO3, 1.2 mM MgCl2, 2.5 mM CaCl2 and 11.5 mM glucose and previously bubbled with a mixture of 95% 02 and 5% CO2 for at least 30 min. The longi tudinal segments of mesenteric veins or ar teries (2-3 mm below the portal vein, 8-10 mm long, 0.2-0.4 mm diameter) and vena cava (left superior portion, 5 mm long, 2 mm width) were prepared. The aorta (5-10 mm below the aortic arc) was also isolated and dissected into longitudinal and circular (5 mm long, 2 mm width) strips. Experimental protocol: The smooth muscle segment was tied at both ends with silk threads and suspended in a tissue bath (5 ml) containing the above Krebs' solution, con tinuously aerated and maintained at 37'C. One end was connected to an isometric force transducer (U-gage, type UL-2-240, Shinkoh Tsu-shin), and the other end was anchored to the base of the tissue bath. The tissue was al lowed to equilibrate for 30 min at a pre determined passive tension (95 mg for mesen teric veins and arteries and 100 mg for aorta and vena cava) that developed an optimal ac tive tension when challenged with PGF2a or NA. The changes in the isometric force were recorded through a Biophysiograph 180 sys tem (San-ei) equipped with an amplifier (6L5, San-ei).
The cumulative concentration-response re lationships for LTC4 and LTD4 (0.1 nM-1 /IM), U-46619 (29 nM-29 ,iM), PGF2a and PGI2-Na (0.3 oM-0.3 mM), PGE2 and TRK 100 (0.2 jeM-2 mM), PGD2 (0.3-0.9 mM), NA (60 nM-60 WcM) and PhE (50 nM-50 tiM) were obtained by adding the drugs directly to the tissue bath in cumulative con centrations. Each concentration was allowed to come in contact with the muscle for 1 min. The tissue was then washed out four times and allowed to recover for 30 min. In some cases, the eicosanoids were singly applied. Gingerol (30-300 iiM) was previously added to the bath, and after 5 min when the basal tone was recovered, the eicosanoid or alpha adrenergic agonist was added. After washing out and recovery, the strip was again chal lenged with the agonist alone. The pre and post-control responses were averaged as the control response.
Drugs and data analysis: The following compounds were used: (±)- [6] -gingerol and (±)- [8] -gingerol (the chemical structure is shown in Fig. 1 ), PGF2a (Kaken), PGE1 and PGE2 (Fuji), PGD2 (Funakoshi), the PGI2 derivatives PGI2-Na (Ono) and TRK-100 (Kaken), the TXA2 stable analogue U-46619 (Upjohn), LTC4 and LTD4-monomethyl esters (Paesel), arachidonic acid (Sigma), dl-NA (Sankyo), I-PhE (Sigma) and clonidine (Tokyo Kasei). (+)- [6] and (±) [8] -Gingerols were prepared in racemic modifications (5), and they were solubilized in distilled water with the aid of a sonicator (UR-20P, Tomy Seiko) just before use. PG F2a, PG E1, PGE2 and PGD2 were also dissolved in distilled water by the sonicator before use. TRK-100, PhE and clonidine were dissolved in distilled water. PGI2-Na and arachidonic acid were dissolved in 0.1% ethanol. U-46619 was provided in a methyl acetate solution at a concentration of 10 mg/ ml. The methyl acetate was first removed by a vacuum, and the compound then prepared at the desired concentration using 0.1 % ethanol. LTC4 and LTD4-monomethylesters were hydrolyzed using K2CO3 solution (10 mg/0.2 ml) and allowed to stand overnight at room temperature before use.
The concentrations of the drugs were ex pressed as the final molar concentration in the tissue bath. The changes in tension were con verted to the percentage of the maximal response. Statistical analysis was made using paired Student's t-test or the Studentized range test after the one-way or two-way an alysis of variance.
Results
Effects of gingerols on noradrenaline and phenylephrine-induced contraction: Cumula tive addition of NA and PhE induced concen tration-dependent contraction of mouse mes Fig. 1 . Chemical structure of the gingerols used in the investigation. n=6 and 8 for (±)- [6] and (f)
[8]-gingerols, respectively.
enteric veins. The maximum response to PhE was about 12% less than NA. In contrast, clonidine failed to contract the muscle even at high concentrations (0.3 mM). (±)- [6] Gingerol at 0.1 and 0.3 mM significantly inhibited the contractile response to NA ( Fig.  2 ) and increased the EC50 values (Table 1) in a concentration-dependent manner, as estimated by two-way analysis of variance (Table 2 ). (±)- [6] -Gingerol (0.3 mM) also induced significant inhibition of PhE con traction by one-way analysis of variance followed by the Studentized range test (Fig. 2 , Table 1 ). The same patterns of both inhibition of NA responses and shift in the EC50 values were elicited by (±)- [8] -gingerol (Table 1) .
Direct contractile responses to prostanoids and leukotrienes in longitudinal segments of isolated mesenteric veins of mice: Cumulative addition of prostaglandins (F2a, E2 and D2), prostacyclin stable derivatives (PGI2-Na and TRK-100), the stable TXA2 (U-46619), and leukotrienes (C4 and D4) caused concentra tion-dependent contraction of mouse mesen teric veins. The maximal contraction for PGF2a was obtained at a concentration of 0.28 mM. PGE2 and PGD2 (0.28 mM) caused 48% and 12% of the maximal response to PGF2a, re spectively. PG12-Na (0.27 mM) produced the same maximal contraction as PGF2a. The other prostacyclin derivative TRK-100 (0.24 mM) induced a contraction that was 27% of the maximal response for PGF2a. The muscle strips were more sensitive to U-4661 9, LTC4 and LTD4; higher amplitudes of contraction were obtained at low concentrations: 152%, 179% and 163%, respectively, for U-46619 (29 itM), LTC4 (1 iiM) and LTD4 (1 tcM). Arachidonic acid and PGE, failed to cause contraction even at high concentrations (0.3 mM) (data not shown).
Effects of gingerols on prostanoid and leukotriene-induced contraction: The effects of (+)- [6] -gingerol at 0.03-0.3 mM on the cumulative concentration-contraction curve for PGF2a were investigated.
(±) [6] Gingerol significantly potentiated the PGF2a induced maximal contraction (Fig. 3) , which was evaluated by the Studentized range test, and decreased the EC50 values (Table 1) in a concentration-dependent manner. The con centration dependency of gingerol and PGF2a was confirmed by the two-way analysis of variance ( Table 2 ). The same pattern of poten tiation was observed with 0.03-0.1 mM (+) [8] -gingerol (Table 1) . Figure 4 shows typical recordings of the mesenteric vein contraction response to max imum concentrations of PGF2a, PGE2 and TRK-100 in the absence or presence of (±) [6] -gingerol. The gingerol alone caused a transient relaxation; and then after 5 min, it significantly potentiated the prostanoid-in duced contraction. The response to TRK-100 The contractions induced by prostaglandin (PG) F2a, thromboxane A2 derivative (U-4661 9), leukotriene (LT), noradrenaline (NA) and phenylephrine (PhE) without gingerol were used as the control, and the values are expressed as 50% response with confidence limits. The maximum contraction induced by PGF2a was taken as 100% response. The values are expressed as mean percentages+S.E.M., n=4-12.
Significant differences from the control response without (±)- [6] -gingerol at *P<0.05 and **P<0.01 in the Studentized range test.
was the most markedly potentiated. The effects of (±)- [6] and (d)- [8] gingerols on other eicosanoid-induced con traction were evaluated. As shown in Table  3 , compared to the control (without gingerol), the contraction induced by prostanoids except aThe contraction to PGF2a (0.3 uM-0.3 mM) without gingerol was used as the control, and the values are expressed as 50% response with con fidence limits. bThe contraction to PGF2a (0.3 mM) without gingerol was used as the control=100% response, and the values are expressed as mean percentage±S.E.M.
(n=4). Significant difference from the control value without gingerol at *P<0.05 and **P<0.01 by the paired t-test.
PGD2 was significantly enhanced by ginger ols. In contrast, the contraction induced by PGD2, U-46619, LTC4 and LTD4 was signifi cantly inhibited by gingerols.
(±)- [8] Gingerol was more potent overall than (±) [6] -gingerol.
The effects of the gingerols disappeared completely after a wash-out of 30 min to 1 hr.
Reverse effects in vein and artery of (±) [6] -gingerol on PG F2,,-induced contraction: The experiments on longitudinal segments of mouse mesenteric veins were repeated in dif ferent blood vessels. The effects of gingerol were further compared between species (mouse and rat), between vein (vena cava and mesenteric vein) and artery (aorta and mesenteric artery), and between longitudinal and circular segments (Table 4 ). All the blood vessels used except the longitudinal segments of rat aorta and mesenteric artery contracted in response to PGF2a. The latter two vessels were relaxed by PGF2a from the basal force.
(±)- [6] -Gingerol potentiated the PGF2a induced contraction in longitudinal segments of mouse and rat veins, and it decreased PGF2a-induced relaxation in longitudinal seg ments of rat artery. In contrast, in circular segments of rat aorta and longitudinal seg ments of mouse mesenteric artery, (±)- [6] gingerol inhibited the PGF2a-induced con traction.
Discussion
The prostaglandins (PGF2a, PGE2, PGD2, PG12), TX and LT induce concentration dependent contraction of various blood ves sels. In isolated dog arteries pre-contracted with K+ solution, PGH2 produced a rapid con traction followed by a transient relaxation and a sustained contraction (6) . In rabbit and rat aorta (7), human coronary artery (8) and canine basilar artery (9), low doses of PGI2 relax the vascular smooth muscle, but higher doses elicit concentration-dependent con tractile responses. In the present study, the prostanoids and LT induced concentration dependent contraction in mouse mesenteric veins. The longitudinal segments of mouse mesenteric artery, rat mesenteric vein and vena cava and the circular segments of the rat aorta also contracted in response to PGF2a. On the other hand, PGF2a relaxed the longi tudinal segments of rat aorta and mesenteric artery.
Both LT and the TXA2 derivative produced a response of higher sensitivity and greater maximal response than other prostaglandins. The order of potency of the prostanoids and LT was estimated to be LTs> (TXA2) > PG F2a > PGI2 Na > PG E2 > TR K-100 > PG D2 for mouse mesenteric vein. These responses were similar to those obtained for guinea pig lung (10) and isolated human bronchus (11) . This suggests that the mouse mesenteric veins contain more than one type of eicosanoid re ceptor-mediating contraction. The receptor: for prostanoids with lower potency may not be so abundant in the mesenteric veins of these agents may be partial agonists.
The mechanism by which the components of ginger affects prostanoids synthesis re mains controversial. Collier et al. (12) has shown that zingerone, a component of ginger, increased the synthesis of PGE2 and PGF20 by stimulation of prostaglandin synthetase ex tracted from bull seminal vesicles. On the other hand, Kiuchi et al. (13) reported that [6] -gingerol and four other constituents from ginger, namely, [6] and [10]-dehydroginger dione and [6] and [10]-gingerdione, were potent inhibitors of prostaglandin biosyn thesis. Aburada (14) also reported that [6] gingerol and [6] -shogaol (also a component of ginger) inhibited the cyclooxygenase enzyme activity in rabbit platelets and rat aorta.
In the present study, (±)- [6] or (±)-[8] gingerol alone induced transient relaxation which then recovered to the baseline force, but did not induce direct contractile effects. However, (±)- [6] and (±)- [8] -gingerols potentiated the contraction response to PGF2a, PGI2 and PGE2, but inhibited the con traction induced by LT, TXA2 and PGD2. The inhibition of TXA2 synthesis (15) and the LT receptors (16) has been reported to convert arachidonic acid to PGE2, PGF2a and PGI2 via the cyclooxygenase pathway. The results of the present study suggest that gingerol induced potentiation of prostanoid contrac tion (except PGD2) is related to the cyclooxy genase system. This hypothesis however requires further elucidation and is now under investigation.
The effects of gingerols on other agonists involved in the contractility of vascular smooth muscles were also investigated. The mouse mesenteric veins also contracted in response to NA and PhE, the former being more potent than the latter, but did not con tract in response to clonidine. These find ings correspond to those obtained in the rabbit vas deferens (17).
In vesicourethral smooth muscles, the con traction induced by PGE2, PGF2a and PGI2 is dependent on extracellular calcium influx (18). The alpha adrenergic receptors mediate the PGE production in rabbit vas deferens (17). In rat aortic rings, NA-stimulated 6-keto PGF2a synthesis was dependent on extra cellular calcium (19). We have previously reported that (±)- [6] -gingerol inhibition of spontaneous contraction in mouse portal veins (anatomically connected to the mesen teric vein) was dependent on calcium influx, but the inhibition of contraction induced by (±)- [8] -gingerol is independent of extra cellular calcium (3) . In the present study, (±)- [6] and (±)- [8] -gingerols inhibited the contraction induced by NA and PhE non competitively and concentration-depend ently. These results indicate that gingerol potentiation of prostanoid-induced con traction is independent of extracellular calcium and not mediated by alpha-adrenergic receptors.
(+)- further support the hy pothesis that the effects of (±)- [6] -gingerol involve the cyclooxygenase-related system .
